BIOLASE (BIOL) Stock Chart & Stock Price History $0.01 +0.00 (+13.21%) As of 06/30/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock BIOLASE Stock Price Performance The BIOLASE (BIOL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.00%, with a year-to-date return of 9.09%. In the past month, the stock has increased 16.62%, reflecting recent market activity. As of the latest close, BIOLASE traded at $0.01 with a market cap of $401 thousand and volume of 89,800 shares. Five years ago, the stock traded at a split-adjusted price of $992.50, representing a 100.00% decrease over that period. At the time, it had a market cap of $14.70 million and a volume of 67,145 shares. Receive BIOL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+20.00%1 Month Performance+16.62%3 Month Performance+53.85%Year-To-Date Performance+9.09%1 Year Performance-88.00%5 Year Performance-100.00% BIOL Stock Chart for Wednesday, July, 2, 2025 BIOL Chart by TradingView BIOLASE Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$0.01$0.01+12.68%$0.01$0.0189,800 shs$401,000.0006/30/2025$0.01$0.01$0.01$0.018,254 shs$356,000.0006/27/2025$0.01$0.01-20.00%$0.01$0.015,291 shs$334,000.0006/26/2025$0.01$0.01+19.05%$0.01$0.01173,185 shs$418,000.0006/25/2025$0.01$0.01-4.72%$0.01$0.0143,701 shs$351,000.0006/24/2025$0.01$0.01-8.17%$0.01$0.0180,352 shs$368,000.0006/23/2025$0.01$0.01$0.01$0.0148,896 shs$401,000.0006/20/2025$0.01$0.01$0.01$0.0111,002 shs$398,000.0006/19/2025$0.01$0.01+6.63%$0.01$0.0111,002 shs$398,000.0006/18/2025$0.01$0.01+21.30%$0.01$0.0114,555 shs$373,000.00 Get the Latest News and Ratings for BIOL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$0.01$0.01-14.81%$0.01$0.0116,545 shs$307,000.0006/16/2025$0.01$0.01$0.01$0.0116,265 shs$361,000.0006/13/2025$0.01$0.01+36.26%$0.01$0.0112,880 shs$414,000.0006/12/2025$0.01$0.01-1.09%$0.01$0.0127,986 shs$304,000.0006/11/2025$0.01$0.01-8.00%$0.01$0.014,140 shs$307,000.0006/10/2025$0.01$0.01+2.77%$0.01$0.0113,681 shs$334,000.0006/09/2025$0.01$0.01$0.01$0.0179,727 shs$325,000.0006/06/2025$0.01$0.01$0.01$0.0111,257 shs$304,000.0006/05/2025$0.01$0.01-24.17%$0.01$0.016,242 shs$304,000.0006/04/2025$0.01$0.01$0.01$0.0122,287 shs$401,000.0006/03/2025$0.01$0.01+16.62%$0.01$0.01198,496 shs$401,000.0006/02/2025$0.01$0.01$0.01$0.0133,519 shs$344,000.00 Related Companies Avinger Stock Price Chart Nuwellis Stock Price Chart NAYA Biosciences Stock Price Chart Dynatronics Stock Price Chart Cutera Stock Price Chart Sonendo Stock Price Chart Sharps Technology Stock Price Chart Helius Medical Technologies Stock Price Chart Assure Stock Price Chart Acutus Medical Stock Price Chart Receive BIOL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BIOLASE and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIOL) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
